Chemokines and allergic disease

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 4 I, 1999, Pages 723-742

  Nickel, Renate ^a   Beck, Lisa A ^a   Stellato, Cristiana ^a   Schleimer, Robert P ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Allergic disease; Angiogenesis; Chemokine; Chemotaxis; Cytokines; Eosinophil; Glucocorticoid s; Hematopoieses; Mediators; Transendothelial migration

Indexed keywords

ALLERGIC DISEASE; DISEASE PREDISPOSITION; EOSINOPHIL; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; PRIORITY JOURNAL; REVIEW;

EID: 0033495194     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70281-2     Document Type: Article

References (204)

1. Wells TNC, Power CA, Proudfoot AEI. Definition, function and pathophysiological significance of chemokine receptors. TIPS 1998;19:376-80.
2. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, et al. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994;266:1395-9.
3. 3C motif. Nature 1997;385:640-4.
4. Wong M, Fish EN. RANTES and MIP-1a activate STATS in T cells. J Biol Chem 1998;273:309-14.
5. Haribabu B, Richardson RM, Fisher I, Sozzani S, SC Peiper, R Horuk, et al. Regulation of human chemokine receptors CXCR4: role of phosphorylation in desensitization and internalization. J Biol Chem 1997;272:28726-31.
6. Zhao J, Ma L, Wu YL, Wang P, Hu W, Pei G. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J Cell Biochem 1998;71:36-45.
7. Zimmermann N, Conkright JJ, Rothenberg ME. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem 1999;274:12611-8.
8. Oppermann M, Mack M, Proudfoot AE, Olbrich H. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 1999;274:8875-85.
9. Turner SJ, Domin J, Waterfield MD, Ward SG, Westwick J. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J Biol Chem 1998;273:25987-95.
10. Szabo MC, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the duffy antigen-erythrocyte chemokine receptor. J Biol Chem 1995;270:25348-51.
11. Niggs RJB, Wylie SM, Yang J, Landau NR, Graham GJ. Cloning and characterization of a novel promiscuous human β-chemokine receptor D6. J Biol Chem 1997;272:32078-83.
12. Gao J-L, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997;185:1959-68.
13. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-61.
14. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998;187:601-8.
15. Nomiyama H, Imai T, Kusuda J, Miura R, Callen DF, Yoshie O. Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q113. Cytogenet Cezll Genet 1998;81:10-1.
16. Nomiyama H, Osborne LR, Imai T, Kusuda J, Miura R, Tsui L-C, et al. Assignment of the human CC chemokine MPIF-2/eotaxin-2 (SCYA24) to chromosome 7q11.23. Genomics 1998;49:339-40.
17. Modi WS, Chen ZQ. Localization of the human CXC chemokine subfamily on the long arm of chromosome 4 using radiation hybrids. Genomics 1998;47:136-9.
18. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, et al. Structure and chromosomal location of the human stromal cell-derived factor 1 (SDF-1) gene. Genomics 1995;28:495-500.
19. Tunnacliffe A, Majumdar S, Yan B, Poncz M. Genes for beta-thromboglobulin and platelet factor 4 are closely linked and form part of a cluster of related genes on chromosome 4. Blood 1992;79:2896-900.
20. Kennedy J, Kelner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, et al. Molecular cloning and functional characterization of human lymphotactin. J Immunol 1995;155:203-9.
21. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo J-A, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997;387:611-7.
22. Daugherty BL, Springer MS. The β-chemokine receptor genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMKBR3) cluster within 285 kb on human chromosome 3p21. Genomics 1997;41:294-5.
23. Samson M, Soularue P, Vassart G, Parmentier M. The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR-5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 1996;36:522-6.
24. Bonini JA, Martin SK, Dralyuk F, Roe MW, Philipson LH, Steiner DF. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol 1997;16:1249-56.
25. Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995;270:16491-4.
26. Schweickhart VL, Raport CJ, Godiska R, Byers MG, Eddy RL Jr, Shows TB, et al. Cloning of human and mouse EBI1, a lymphoid specific G-protein-coupled receptor encoded on human chromosome 17q11.2-q21.2. Genomics 1994;23:643-50.
27. Bochner BS, Bickel CA, Taylor ML, MacGlashan DW Jr, Gray PW, Raport CJ, et al. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner. J Allergy Clin Immunol 1999;103:527-32.
28. Stellato C, Collins P, Li H, White J, Ponath PD, Newman W, et al. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997;99:926-36.
29. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, et al. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding and function properties provide a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12.
30. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I, Dahinden CA. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 1995;154:4166-72.
31. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994;179:751-6.
32. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-95.
33. Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997;185:2171-6.
34. White JR, Imburgia C, Dul E, Appelbaum E, O'Donnell K, O'Shannessy DJ, et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukot Biol 1997;62:667-757.
35. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, ArenzanaSeisdedos F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
36. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A 1997;94:1925-30.
37. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, et al. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 1997;272:13803-9.
38. Ogata M, Zhang Y, Wang Y, Itakura M, Zhang Y-Y, Harada A, et al. Chemotactic response toward chemokines and its regulation by transforming growth factor-betal of murine bone marrow hematopoietic progenitor cell-derived different subset of dendritic cells. Blood 1999;93:3225-32.
39. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 1999;162:3859-64.
40. Loetscher P, Seitz M, Baggiolini M, Moser M. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996;184:569-77.
41. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-71.
42. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 1994;91:3652-6.
43. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4(+) and CD8(+) T lymphocytes. FASEB J 1994;8:1055-60.
44. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005-7.
45. D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzan S, Mantovani A, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998;161:5111-5.
46. Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998;273:1764-8.
47. Andrew DP, Chang MS, McNinch J, Wathen ST, Rihanek M, Tseng J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes in stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 1998;161:5027-38.
48. Jahnsen FL, Haye R, Gran E, Brandtzaeg P, Johansen F-E. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and MCP-4 in airway inflammation with eosinophilia. J Immunol 1999;163:1545-51.
49. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, et al. High expression of the chemokine receptor CRC3 in human blood basophils. J Clin Invest 1997;100:1137-43.
50. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, et al. Chemokine receptor usage by human eosinophils. J Clin Invest 1997;99:178-84.
51. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-83.
52. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-34.
53. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B. CCR5 is characteristic of Th1 lymphocytes. Nature 1998;391:344-5.
54. Huber AR, Kunkel SL, Todd RF III, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;254:99-102.
55. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines, III: effect of the chemokine RANTES. J Immunol 1994;153:2153-60.
56. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 1993;361:79-82.
57. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997;91:385-95.
58. Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci U S A 1993/90:7158-62.
59. Weber C, Alon R, Moser B, Springer TA. Sequential regulation of a4b1 and a5b1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol 1996;134:1063-73.
60. Weber C, Kitayama J, Springer TA. Differential regulation of b1 and b2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci U S A 1996;93:10939-44.
61. Vaddi K, Newton RC. Regulation of monocyte integrin expression by β-family chemokines. J Immunol 1994;153:4721-32.
62. Tanaka Y, Mine S, Figdor CG, Wake A, Hirano H, Tsukada J, et al. Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. Blood 1998;91:3909-19.
63. Bochner BS, Sterbinsky SA, Tachimoto H. CCR3-active chemokines rapidly inhibit human eosinophil adhesion to VCAM-1 in vitro [abstract]. J Allergy Clin Immunol 1999;103:S114.
64. Carr MW, Alon R, Springer TA. The C-C chemokine MCP-1 differentially modulates the avidity of β1 and β2 integrins on T lymphocytes. Immunity 1996;4:179-87.
65. Maze R, Sherry B, Kwon S, Cerami A, Broxmeyer HE. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1α. J Immunol 1992;149:1004-9.
66. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol 1993;150:3448-58.
67. Lecomte-Raclet L, Alemany M, Grand AS, Amiral J, Quentin G, Vissac AM, New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides. Blood 1998;91:2772-80.
68. Daly TJ, LaRosa GJ, Dolich S, Maione TE, Cooper S, Broxmeyer HE. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. J Biol Chem 1995;270:23282-92.
69. Broxmeyer HE, Cooper S, Cacalano G, Hague HL, Balesh E, Moore MW. Involvement of interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue. J Exp Med 1996;184:1825-32.
70. Zou Y-R, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-9.
71. Tachibana K, Hirota S, Lizasa H, Yoshida H, Kawabata K, Kataoka Y, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998;393:591-4.
72. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, et al. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-8.
73. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci 1998;95:9448-53.
74. Quackenbush EJ, Aguirre V, Wershil BK, Gutierrez-Ramos JC. Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse. J Leukot Biol 1997;62:661-6.
75. Peled A, Gonzalo JA, Lloyd C, Gutierrez-Ramos J-C. The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation. Blood 1998;91:1909-16.
76. Palframan RT, Collins PD, Williams TJ, Rankin SM. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998;91:2240-8.
77. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997;99:1064-71.
78. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
79. Stricter RM, Kunkel SL, Shanafelt AB, Arenberg DA, Kobh AE, Polverini PJ. In: Koch AE, Stricter RM, editors. Chemokines in disease. Austin (TX): RG Landes Biomedical Publishers; 1996. p 195-210.
80. Luster AD, Leder P. IP-10, a C-X-C chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med 1993;178:1057-65.
81. Maione TE, Gray GS, Petro J, Hunt AJ. Inhibition of angiogenesis by recombinant platelet factor 4 and related peptides. Science 1990;247:77-9.
82. Stricter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, et al. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukot Biol 1995;57:752-62.
83. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-83.
84. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster A. Human eotaxin is a specific chemoattractant for eosinophil cells and provides new mechanism to explain tissue eosinophilia. Nat Med 1996;4:449-56.
85. Matthews AN, Friend DS, Zimmermann N, Sarafi MN, Luster AD, Pearlman E, et al. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci U S A 1998;95:6273-8.
86. Luster AD Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
87. Dunnill MS. The pathology of asthma. In: Middleton E, Reed CE, Ellis EF, editors. Allergy principles and practice. 2nd ed. St Louis: CV Mosby; 1978. p 678-86.
88. Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, et al. Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 1996;98:766-80.
89. Laitinen LA, Laitinen A. Remodeling of asthmatic airways by glucocorticoids. J Allergy Clin Immunol 1996;97:153-8.
90. Sousa AR, Lane SJ, Nakhosteen JA, Yoshimura T, Lee TH, Poston RN. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 1994;10:142-7.
91. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996;14:27-35.
92. Teran LM, Noso N, Carroll M, Davies DE, Holgate S, Schröder J-M. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996;157:1806-12.
93. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhvberdi Z, Ghaffar O, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatic contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-601.
94. Gonzalo J-A, Lloyd CM, Kremer L, Finger E, Martinez-A C, Siegelman MH, et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation: the role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996;98:2332-45.
95. Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepeda EA, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
96. Stellato C, Beck LA, Gorgone GA, Proud D, Schall TJ, Ono SJ, et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids. J Immunol 1995;155:410-8.
97. Garcia-Zepeda EA, Combadiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996;157:5613-26.
98. Lilly CM, Nakamura H, Kesselman H, Nagler-Anderson C, Asano K, Garcia-Zepeda EA, et al. Expression of eotaxin by human lung epithelial cells. J Clin Invest 1997;99:1767-73.
99. Levine SJ. Bronchial epithelial cell-cytokine interactions in airway inflammation. J Invest Med 1995;43:241-9.
100. Chung KF. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, editors. Asthma. Philadelphia: Lippincott-Raven; 1997. p 673-82.
101. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J Biol Chem 1993;268:5834-9.
102. Ohmori Y, Schreiber RD, Hamilton TA. Synergy between interferon-g and tumor necrosis-a in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kB. J Biol Chem 1997;272:14899-907.
103. Sampath D, Castro M, Look DC, Holtzman MJ. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J Clin Invest 1999;103:1353-61.
104. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci U S A 1995;92:8960-4.
105. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schröder J-M. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998;160:60-8.
106. Stellato C, Plitt JR, Bickel CA, White J, Schleimer RP. Differential regulation of epithelial-derived C-C chemokines by cytokines and budesonide [abstract]. J Allergy Clin Immunol 1998;101(Suppl):S230.
107. Mochizuki M, Bartels J, Christophers E, Schröder J-M. IL-13 is a potent inducer of eotaxin in dermal fibroblasts [abstract]. J Invest Dermatol 1997;109:A412.
108. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann T, et al. Effects of Th2 cytokines on chemokine expression in the lung: IL13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87.
109. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1086-92.
110. Stellato C, Matsukura S, Fal A, White J, Beck LA, Proud D, et al. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 1999. In press.
111. Matsukura S, Plitt JR, Bickel CA, Stellato C, Georas S, Casolaro V, et al. Molecular analysis of eotaxin gene expression in airway epithelial cells [abstract]. J Allegy Clin Immunol 1999;103(Suppl):S202.
112. Becker S, Reed W, Henderson FW, Noah TL. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am J Physiol 1997;272:L512-207.
113. Matsukura S, Kokubu F, Noda H, Tokunaga H, Adachi M. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 1996;98:1080-7.
114. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus - induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995;96:549-57.
115. Schleimer RP, Hamid Q. In: Marone G, Austen KF, Holgate ST, Kay AB, Lichtenstein LM, editors. Asthma and allergic diseases: physiology, immunopharmacology and treatment. London: Academic Press; 1998. p 337-55.
116. Stellato C, Schwiebert LM, Schleimer RP. In: Barnes PJ, Grunstein MM, Leff A, Woolcock AJ, editors. Asthma. Philadelphia: Lippincott-Raven; 1997. p 1569-96.
117. Wingett D, Forcier K, Nielson C. Glucocorticoid-mediated inhibition of RANTES expression in human T lymphocytes. FEBS Lett 1996;398:308-11.
118. Berkman N, Robichaud A, Krishnan V, Roesems G, Robbins R, Jose P, et al. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology 1996;87:599-603.
119. Selvan RS, Butterfield JH, Krangel MS. Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 1994;269:13893-8.
120. Miyamasu M, Misaki Y, Izumi S, Takaishi T, Morita Y, Nakamura H, et al. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol 1998;101:75-83.
121. Cooper JAD, Fuller JM, McMinn KM, Culbreth RR. Modulation of monocyte chemotactic protein-1 production by hyperoxia: importance of RNA stability in control of cytokine production. Am J Respir Cell Mol Biol 1998;18:521-5.
122. Slavin J, Unemori E, Hunt T, Amento E. Monocyte chemotactic protein-1 (MCP-1) mRNA is down-regulated in human dermal fibroblasts by dexamethasone: differential regulation by TGF-b. Growth Factors 1995;12:151-7.
123. Berkman N, Jose PJ, Williams TJ, Schall TJ, Barnes PJ, Chung KF. Corticosteroid inhibition of macrophage inflammatory protein-1a in human monocytes and alveolar macrophages. Am J Physiol 1995;269:L443-52.
124. Tsai M-J, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994;63:451-86.
125. Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 1985;19:209-52.
126. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transaction factor NF-kB and the glucocorticoid receptor. Proc Natl Acad Sci U S A 1994;91:752-6.
127. Ponta H, Cato ACB, Herrlich P. Interference of pathway specific transcription factors. Biochim Biophys Acta Gene Struct Expression 1992;1129:255-61.
128. Schüle R, Rangarajan P, Kliewer S, Ransome LJ, Bolado J, Yang N, et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990;62:1217-26.
129. Mukaida N, Gussella G, Kasahara T, Ko Y, Zachariae C, Kawai T, et al. Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line. Immunology 1992;75:674-9.
130. Hein H, Schlüter C, Kulke R, Christophers E, Schröder J-M, Bartels J. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun 1997;237:537-42.
131. Garcia-Zepeda EA, Rothenberg ME, Weremowicz S, Sarafi MN, Morton CC, Luster AD. Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), and eosinophil-specific CC chemokine. Genomics 1997;41:471-6.
132. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S-I, Kasahara T, et al. Novel mechanism of glucocorticoid-mediated gene repression. J Biol Chem 1994;269:13289-95.
133. Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol 1997;27:1091-7.
134. Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 1997;158:3483-91.
135. Chen C-YA, Shyu A-B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biol Sci 1995;20:465-70.
136. Yoshimura T, Yuhki N, Moore SK, Appela E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1): full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989;244:487-93.
137. Zipfel PF, Balke J, Irving S, Kelly K, Siebenlist U. Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors. J Immunol 1989;142:1582-90.
138. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF by interleukin 1 and tumor necrosis factor. J Exp Med 1988;167:1883-93.
139. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988;141:1018-25.
140. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 1995;12:488-96.
141. Beck LA, Dalke S, Leiferman KM, Bickel CA, Hamilton R, Rosen H, et al. Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic subjects. J Immunol 1997;159:2962-72.
142. Meurer R, Van Riper G, Feeney W, Cunningham P, Hora D Jr, Springer MS, et al. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein I, human macrophage inflammatory protein la, or human interleukin 8. J Exp Med 1993;178:1913-21.
143. Khorram O, Taylor RB, Ryan IP, Schall TJ, Landers DV. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993;169:1545-9.
144. Snowden N, Hajeer A, Thomson W, Ollier B. RANTES role in rheumatoid arthritis. Lancet 1994;343:547-8.
145. Devergne O, Marfaing-Koka A, Schall TT, Leger-Ravet M-B, Sadick B, Peuchmaur M, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689-94.
146. Beck LA, Brummet ME, Seminario MC, Saini SS, Ponath PD, Bochner BS, et al. Surface expression of the chemokine receptor CCR3 on human eosinophils correlates with the activation marker CD44 [abstract]. J Allergy Clin Immunol 1999;103(Suppl):A433.
147. Lee SC, Brummet MD, Woodworth TG, Leiferman KM, Gilman SC, Gladue RP, et al. Cutaneous injection of human subjects with macrophage inflammatory protein-1a causes significant leukocyte recruitment. J Immunol 1998. In press.
148. Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1a and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994;152:1298-303.
149. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-7.
150. Beck L, Brummet M, Bickel C, Leiferman K, Andresen C, Gilman S, et al. Cutaneous injections with C-C chemokines: a comparative study in cynomologous macaques [abstract]. J Allergy Clin Immunol 1998;101(Suppl):S36.
151. Teixeira MM, Wells TNC, Lukacs NW, Proudfoot AEI, Kunkel SL, Williams TJ, et al. Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest 1997;100:1657-66.
152. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993;197:1167-72.
153. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, et al. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996;2:334-48.
154. Kuna P, Alam R, Ruta U, Gorski P. RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am J Respir Crit Care Med 1998;157:873-9.
155. Ying S, Taborda-Barata L, Meng Q, Humbert M, Kay AB. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 1995;181:2153-9.
156. Meng Q, Ying S, Robinson DS, McEuen AR, Buckley MG, Walls A, et al. Kinetic expressin of mRNA for CC chemokines eotaxin, eotaxin-2, MCP-4, MCP-3 and RANTES and their receptor CCR3 in allergen-induced skin late phase reactions (LPR): relationship of infiltration of eosinophils and basophils [abstract]. J Allergy Clin Immunol 1999;103(Suppl):S54.
157. Zweiman B, Kaplan AP, Tong L. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin. J Allergy Clin Immunol 1997;100:104-9.
158. Teran LM, Park H-S, Djukanovic R, Roberts K, Holgate S. Cultured nasal polyps from nonatopic and atopic patients release RANTES spontaneously and after stimulation with phytoemagglutinin. J Allergy Clin Immunol 1997;100:499-504.
159. Hamilos DL, Leung DYM, Huston DP, Kamil A, Wood R, Hamid Q. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy. 1998;28:1145-52.
160. Bartels J, Maune S, Meyer JE, Kulke R, Schluter C, Rowert J, et al.
161. Venge J, Lampinen M, Hakansson L, Rak S, Venge P. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol 1996;97:1110-5.
162. Powell N, Humbert M, Durham SR, Assoufi B, Kay AB, Corrigan CJ. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J 1996;9:2454-60.
163. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, et al. Increased MCP-1, RANTES, and MIP-1a in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996;153:1398-404.
164. Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R, et al. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol 1997;16:1-8.
165. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1a, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997;156:1377-83.
166. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, Ringler DJ, et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997;27:3507-16.
167. Mattoli S, Stacey MA, Sun G, Bellini A, Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun 1997;236:299-301.
168. Sur S, Kita H, Gleich GJ, Chenier TC, Hunt LW. Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. J Allergy Clin Immunol 1996;97:1272-8.
169. MacLean JA, Ownbey R, Luster AD. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J Exp Med 1996;184:1461-9.
170. Lukacs RW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997;158:4398-404.
171. Gonzalo J-A, Lloyd CM, Wen D, Albar JP, Wells TNC, Proudfoot A, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 1998;188:157-67.
172. Chensue SW, Warmington KS, Allenspach EJ, Lu B, Gerard C, Kunkel SL, et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicted granulomatous inflammation. J Immunol 1999;163:165-73.
173. Li L, Xia Y, Bguyen A, Feng L, Lo D. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J Immunol 1999;161:3128-35.
174. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997;185:785-90.
175. Yang Y, Loy J, Ryseck RP, Carrasco D, Bravo R. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood 1998;92:3912-23.
176. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995/152:927-33.
177. Weido AJ, Reece LM, Alam R, Cook CK, Sim TC. Intranasal fluticasone dipropionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol 1996;77:407-15.
178. Conroy DM, Humbles AA, Rankin SM, Palframan RT, Collins PD, Griffiths-Johnson DA, et al. The role of the eosinophil-selective chemokine, eotaxin, in allergic and non-allergic airways inflammation. Mem Inst Iswaldo Cruz 1997;92(2 Suppl):183-91.
179. Stafford S, Forsythe PA, Ryan M, Bravo R, Alam R. Monocyte-chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J Immunol 1997;158:4953-60.
180. Sabroe I, Conroy DM, Gerard NP, Li Y, Collins PD, Post TW, et al. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-1: blockade using a monoclonal antibody in vivo. J Immunol 1998;161:6139-47.
181. Schwartz J, Gold D, Dockery DW, Weiss ST, Speizre FE. Predictors of asthma and persistent wheeze in a national sample of children in the United States. Am Rev Respir Dis 1990;142:555-62.
182. Gold DR, Rotnitzky A, Damokosh AI, Ware JH, Speizer FE, Ferris BG, et al. Race and gender differences in respiratory illness prevalence and their relationship to environmental exposures in children 7 to 14 years of age. Am Rev Respir Dis 1993;148:10-8.
183. Nelson DA, Johnson CC, Divine GW, Strauchmann C, Joseph CLM, Ownby DR. Ethnic differences in the prevalence of asthma in middle class children. Ann Allergy Asthma Immunol 1997;78:21-6.
184. Sarpong SB, Hamilton RG, Eggleston PA, Adkinson NF Jr. Socioeconomic status and race as risk factors for cockroach allergen exposure and sensitization in children with asthma. J Allergy Clin Immunol 1996;97:1393-401.
185. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999;103:125-38.
186. Grundbacher FJ. Causes of variation in serum IgE levels in normal populations. J Allergy Clin Immunol 1975;56:104-11.
187. Grundbacher FJ. Levels of immunoglobulin G, M, A, and E at various ages in allergic and nonallergic black and white individuals. J Allergy Clin Immunol 1985;75:651-8.
188. Collaborative Study of the Genetics of Asthma (CSGA). A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997;15:389-92.
189. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, et al. A genome wide search for quantitative trait loci underlying asthma. Nature 1996;383:247-50.
190. Wjst M, Fischer G, Immervoll T, Jung M, Saar K, Rueschendorf F, et al. A genome-wide search for linkage to asthma. Genomics 1999;58:1-8.
191. Nickel R, Barnes KC, Sengler Ca, Casolaro V, Friedhoff LR, Weber P, Evidence for linkage of chemokine polymorphisms to asthma in populations of African descent [abstract]. J Allergy Clin Immunol 1999;103(Suppl):S174.
192. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992;80:575-81.
193. Bergmann RL, Edenharter G, Bergmann KE, Guggenmoos-Holzmann I, Forster J, Bauer CP, et al. Predictability of early atopy by cord blood-IgE and parental history. Clin Exp Allergy 1997;27:752-60.
194. Samson M, Libert F, Doranz BJ, Rucker J, Liesngard C, Farber C-M, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
195. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
196. Martinson JJ, Chapman NH, Rees DC, Liu Y-T, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997;16:100-3.
197. Nickel RG, Willadsen SA, Friedhoff LR, Huang S-K, Bleecker E, T B, et al. Determination of Duffy-phenotypes in three populations of African descent using PCR and sequence specific oligonucleotides. 1999. In press.
198. Miller LH, Mason SJ, Clyde DF, McGinnis MH. The resistance factor to Plasmodium vivax in blacks: the Duffy-blood-group genotype, FyFy. N Engl J Med 1976;295:302-4.
199. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997;89:3077-91.
200. Chaudhuri A, Nielsen S, Elkjaer M-L, Zbrzezna V, Fang F, Pogo AO. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997;89:701-12.
201. Neote K, Mak JY, Kolakowski LF, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994;84:44-52.
202. Tournamille C, Colin Y, Cartron JP, LeVanKim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10:224-8.
203. Liggett SB. In: Liggett S, Meyers D, editors. The genetics of asthma. New York: Marcel Dekker; 1996. p 455-78.
204. Drazen JM, Yandava CN, Dube L, Szczerback N, Hippenstell R, Pillari A, Pharmacogentic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999;22:168-70.